Smith, Moore & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$210K | – | 387 |
|
|
2022
Q3 | $210K | Hold |
3,000
| – | – | 0.03% | 346 |
|
|
2022
Q2 | $201K | Buy |
+3,000
| New | +$201K | 0.03% | 359 |
|
|
2022
Q1 | – | Sell |
-2,000
| Closed | -$293K | – | 438 |
|
|
2021
Q4 | $293K | Buy |
2,000
+500
| +33% | +$73.3K | 0.04% | 331 |
|
|
2021
Q3 | $265K | Buy |
+1,500
| New | +$265K | 0.04% | 334 |
|